SUCAMPO PHARMACEUTICALS, INC. Proceeds from Notes Payable
SUCAMPO PHARMACEUTICALS, INC. reported Proceeds from Notes Payable of $290.50 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2017-03-08
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2013-12-31 was $0.00.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2013-09-30 was $0.00.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2013-06-30 was $0.00.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for the quarter ending 2013-03-31 was $10.60M.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2016 was $290.50M, a 23.14% increase from fiscal 2015.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2015 was $235.91M.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2013 was $10.60M.
- SUCAMPO PHARMACEUTICALS, INC. proceeds from notes payable for fiscal 2010 was $12.08M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2016-12-31 | $290.50M 10-K · filed 2017-03-08 | |||
| 2015-12-31 | $235.91M 10-K · filed 2017-03-08 | |||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-03-16 | $0.00 derived: sum of 2 quarters · filed 2016-03-16 | $0.00 derived: sum of 3 quarters · filed 2016-03-16 | $10.60M 10-K/A · filed 2016-03-16 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | $10.60M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $10.60M 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | $10.60M 10-Q · filed 2014-05-09 | |||
| 2010-12-31 | $12.08M 10-K · filed 2013-03-18 |